Sumitomo Pharma has a total of 7063 patents globally, out of which 2568 are granted. Out of these 7063 patents, 47.89% are currently active. Sumitomo has filed the maximum number of patents in Japan followed by United States of America, the China, making these regions its major innovation hubs. In line with this, Japan also serves as Sumitomo’s primary R&D focus area. The company is headquartered in Osaka, Japan.
Sumitomo Pharma, founded in 1897, is a global pharmaceutical company focused on research and innovation. It develops, manufactures, and markets specialty and generic medicines. Its portfolio covers areas such as psychiatry and neurology, cardiovascular and diabetes care, oncology, and other specialty therapies. The company is committed to improving patient access to high-quality treatments worldwide.
Do read about some of the most popular patents of Sumitomo Pharma which have been covered by us in this article and also you can find Sumitomo Pharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sumitomo Pharma patent portfolio.
How many patents does Sumitomo Pharma have?
Sumitomo Pharma has a total of 7063 patents globally. These patents belong to 2793 unique patent families. Out of 7063 patents, 3382 patents are active.
How Many Patents did Sumitomo Pharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Sumitomo Pharma Applications Filed | Sumitomo Pharma Patents Granted |
| 2025 | 73 | 215 |
| 2024 | 138 | 228 |
| 2023 | 279 | 207 |
| 2022 | 436 | 261 |
| 2021 | 493 | 203 |
| 2020 | 654 | 201 |
| 2019 | 584 | 156 |
| 2018 | 412 | 142 |
| 2017 | 422 | 157 |
| 2016 | 458 | 171 |
How many Sumitomo Pharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Sumitomo Pharma File in Different Countries?
Top Countries in which Sumitomo Pharma Filed Patents
| Country | Patent |
| Japan | 1036 |
| United States Of America | 853 |
| China | 513 |
| Europe (EPO) | 509 |
| Hong Kong (S.A.R.) | 420 |
| Canada | 368 |
| Australia | 305 |
| Taiwan | 304 |
| South Korea | 294 |
| Mexico | 154 |
| India | 152 |
| Singapore | 137 |
| Israel | 129 |
| Brazil | 124 |
| Indonesia | 84 |
| Spain | 79 |
| Malaysia | 79 |
| South Africa | 72 |
| Russia | 72 |
| Philippines | 62 |
| Viet Nam | 59 |
| Denmark | 52 |
| Eurasia | 49 |
| New Zealand | 46 |
| Portugal | 37 |
| Turkey | 35 |
| Argentina | 35 |
| Poland | 34 |
| Hungary | 26 |
| Thailand | 24 |
| Slovenia | 16 |
| Croatia | 12 |
| Ireland | 11 |
| Republic Of Moldova | 10 |
| Finland | 9 |
| Uruguay | 9 |
| Ukraine | 9 |
| Morocco | 8 |
| Colombia | 7 |
| Lithuania | 7 |
| Saudi Arabia | 6 |
| Cuba | 6 |
| Bulgaria | 6 |
| Costa Rica | 4 |
| United Kingdom | 3 |
| Chile | 3 |
| Latvia | 3 |
| Serbia | 3 |
| Austria | 3 |
| Macao | 2 |
| Africa | 4 |
| El Salvador | 2 |
| Tunisia | 2 |
| Germany | 2 |
| Romania | 2 |
| Netherlands | 1 |
| France | 1 |
| Norway | 1 |
| Luxembourg | 1 |
Where are Research Centres of Sumitomo Pharma Patents Located?
10 Best Sumitomo Pharma Patents
US9040062B2 is the most popular patent in the Sumitomo Pharma portfolio. It has received 521 citations so far from companies like Companies Cilag Gmbh International, Janssen Biotech, Inc. and Ethicon Endo-Surgery, Inc.
Below is the list of 10 most cited patents of Sumitomo Pharma ceutical:
| Publication Number | Citation Count |
| US9040062B2 | 521 |
| US20090118263A1 | 207 |
| US20070225303A1 | 200 |
| US20090105212A1 | 170 |
| WO2013118805A1 | 158 |
| US20110028715A1 | 156 |
| US7351206B2 | 133 |
| WO2011062253A1 | 130 |
| WO2012066336A1 | 128 |
| WO2008136457A1 | 123 |
What Percentage of Sumitomo Pharma US Patent Applications were Granted?
Sumitomo Pharma (Excluding its subsidiaries) has filed 556 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 343 have been granted leading to a grant rate of 79.95%.
Below are the key stats of Sumitomo Pharma patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Sumitomo Pharma?
| Law Firm | Total Applications | Success Rate |
| Birch Stewart Kolasch & Birch | 163 | 79.00% |
| Oblon Mcclelland Maier & Neustadt | 98 | 86.21% |
| Sughrue Mion | 59 | 71.84% |
| Wenderoth Lind & Ponack | 42 | 98.08% |
| Fish & Richardson | 38 | 97.06% |
| Morgan Lewis & Bockius | 37 | 100.00% |
| Leydig Voit & Mayer Ltd | 35 | 80.00% |
| Finnegan Henderson Farabow Garrett & Dunner | 11 | 90.00% |
| Haley Guiliano Llp | 6 | 100.00% |
| Wolf Greenfield & Sacks PC | 5 | 100.00% |
What are Sumitomo Pharma key innovation segments?
What Technologies are Covered by Sumitomo Pharma?
The chart below distributes patents filed by Sumitomo Pharma in different countries on the basis of the technology protected in patents. It also represents the markets where Sumitomo Pharma thinks it’s important to protect particular technological inventions.
R&D Focus: How has Sumitomo Pharma search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Sumitomo Pharma?
